LineaGen Acquired by Bionano Genomics, Inc.
1 known investors
Bionano Genomics develops optical genome mapping (OGM) systems, software, and analysis tools for detecting structural variants and chromosomal aberrations in genomic samples. The company serves clinical laboratories, research institutions, and therapeutic companies working on cancer diagnosis, genetic disease detection, and cell therapy quality control.
BiotechDeep TechMedical Devices